Ultrasound-guided femoral venous access decreases vascular complications in catheter ablation procedures

F Friederike Pavel S S. C. R. Erlhöfer J J. Wörmann S S. Dittrich C C. Scheurlen K K. Filipovic J J.-H. Schipper J J.-H. van den Bruck A A. Sultan J J. Lüker D D. Steven

Abstract

Abstract Ultrasound (US) guidance is increasingly used in invasive cardiac electrophysiology (EP) procedures for femoral vascular access. In this study, we assessed the occurrence of vascular access-related complications in EP procedures which were performed with the routine use of anatomical landmark (LM) versus US-guided vascular access. A total of 1119 consecutive EP procedures in 1012 patients performed in a two-year period from September 10, 2020 to September 10, 2022 were included. The endpoint of the present study consisted of any vascular access-related complication, classified as hematoma, aneurysm, or AV-fistula. Different risk factors for increased bleeding risk were analyzed. During the evaluation period, 777 procedures were performed using LM-guiding and 342 procedures using US-guided access. Overall, 19 (1.7%) relevant vascular complications occurred including: 15 (1.3%) hematoma, 2 (0.18%) aneurysm and 2 (0.18%) AV-fistula. 17 (2.2%) complications occurred in the LM-guided group and 2 (0.6%) in the US-guided group. A significant reduction of femoral complications by 89% was observed with introduction of routine US-guided access. 3.8% in the LM-group vs. 0.4% in the US-group (OR 0.1, 95% CI 0.0135–0.8515, p  = 0.034). Intraprocedural ACT and the HASBLED score [range 0–4; mean = 1.47; maximum = 4) were shown to be independent predictors for vascular complications (OR 2.826, 95% CI 1.631–4.895, p  < 0.001). The use of US-guided vascular access significantly decreased the access-related complication rate in EP procedures. Higher procedural ACT and HASBLED score independently predicted a higher risk of vascular access complications.

Article Details

Volume / Issue Vol. 15, Issue 1
Published October 03, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (11)

F

Friederike Pavel

S

S. C. R. Erlhöfer

J

J. Wörmann

S

S. Dittrich

C

C. Scheurlen

K

K. Filipovic

J

J.-H. Schipper

J

J.-H. van den Bruck

A

A. Sultan

J

J. Lüker

D

D. Steven